Medicxi Ventures Management (Jersey) LTD Portfolio Holdings

Medicxi Ventures Management (Jersey) LTD

  • $455 Million
  • Q4 2024

Medicxi Ventures Management (Jersey) LTD has filed its 13F form on January 23, 2025 for Q4 2024 where it was disclosed a total value porftolio of $455 Million distributed in 5 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Centessa Pharmaceuticals PLC with a value of $334M, Phathom Pharmaceuticals, Inc. with a value of $60.6M, Rapt Therapeutics, Inc. with a value of $35.3M, Aura Biosciences, Inc. with a value of $25M, and Newamsterdam Pharma CO Nv Shs with a value of $0.

Examining the 13F form we can see an decrease of $26M in the current position value, from $481M to 455M.

Below you can find more details about Medicxi Ventures Management (Jersey) LTD portfolio as well as his latest detailed transactions.

Portfolio value $455 Million
Healthcare: $455 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$35M
$35.3 Million 7.76% of portfolio
22,352,000
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 5
  • Current Value $455 Million
  • Prior Value $481 Million
  • Filing
  • Period Q4 2024
  • Filing Date January 23, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Medicxi Ventures Management (Jersey) LTD Portfolio

Follow Medicxi Ventures Management (Jersey) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Medicxi Ventures Management (Jersey) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Medicxi Ventures Management (Jersey) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email